Cargando…
Su1480: TREATMENT-EMERGENT COVID-19 INFECTIONS IN OZANIMOD ULCERATIVE COLITIS AND MULTIPLE SCLEROSIS CLINICAL TRIALS
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AGA Institute. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212334/ http://dx.doi.org/10.1016/S0016-5085(22)61402-1 |
| _version_ | 1784730560535461888 |
|---|---|
| author | Ungaro, Ryan C. Siegel, Corey A. Cree, Bruce Selmaj, Krzysztof Ahmad, Harris Pai, Ashwini Ather, Shabana Henry, Alyssa Charles, Lorna Petersen, AnnKatrin Cheng, Chun-Yen Afsari, Sonia Sheffield, James K. Vaile, John Colombel, Jean Frederic |
| author_facet | Ungaro, Ryan C. Siegel, Corey A. Cree, Bruce Selmaj, Krzysztof Ahmad, Harris Pai, Ashwini Ather, Shabana Henry, Alyssa Charles, Lorna Petersen, AnnKatrin Cheng, Chun-Yen Afsari, Sonia Sheffield, James K. Vaile, John Colombel, Jean Frederic |
| author_sort | Ungaro, Ryan C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9212334 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AGA Institute. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92123342022-06-22 Su1480: TREATMENT-EMERGENT COVID-19 INFECTIONS IN OZANIMOD ULCERATIVE COLITIS AND MULTIPLE SCLEROSIS CLINICAL TRIALS Ungaro, Ryan C. Siegel, Corey A. Cree, Bruce Selmaj, Krzysztof Ahmad, Harris Pai, Ashwini Ather, Shabana Henry, Alyssa Charles, Lorna Petersen, AnnKatrin Cheng, Chun-Yen Afsari, Sonia Sheffield, James K. Vaile, John Colombel, Jean Frederic Gastroenterology AGA Abstracts AGA Institute. Published by Elsevier Inc. 2022-05 2022-06-16 /pmc/articles/PMC9212334/ http://dx.doi.org/10.1016/S0016-5085(22)61402-1 Text en Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | AGA Abstracts Ungaro, Ryan C. Siegel, Corey A. Cree, Bruce Selmaj, Krzysztof Ahmad, Harris Pai, Ashwini Ather, Shabana Henry, Alyssa Charles, Lorna Petersen, AnnKatrin Cheng, Chun-Yen Afsari, Sonia Sheffield, James K. Vaile, John Colombel, Jean Frederic Su1480: TREATMENT-EMERGENT COVID-19 INFECTIONS IN OZANIMOD ULCERATIVE COLITIS AND MULTIPLE SCLEROSIS CLINICAL TRIALS |
| title | Su1480: TREATMENT-EMERGENT COVID-19 INFECTIONS IN OZANIMOD ULCERATIVE COLITIS AND MULTIPLE SCLEROSIS CLINICAL TRIALS |
| title_full | Su1480: TREATMENT-EMERGENT COVID-19 INFECTIONS IN OZANIMOD ULCERATIVE COLITIS AND MULTIPLE SCLEROSIS CLINICAL TRIALS |
| title_fullStr | Su1480: TREATMENT-EMERGENT COVID-19 INFECTIONS IN OZANIMOD ULCERATIVE COLITIS AND MULTIPLE SCLEROSIS CLINICAL TRIALS |
| title_full_unstemmed | Su1480: TREATMENT-EMERGENT COVID-19 INFECTIONS IN OZANIMOD ULCERATIVE COLITIS AND MULTIPLE SCLEROSIS CLINICAL TRIALS |
| title_short | Su1480: TREATMENT-EMERGENT COVID-19 INFECTIONS IN OZANIMOD ULCERATIVE COLITIS AND MULTIPLE SCLEROSIS CLINICAL TRIALS |
| title_sort | su1480: treatment-emergent covid-19 infections in ozanimod ulcerative colitis and multiple sclerosis clinical trials |
| topic | AGA Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212334/ http://dx.doi.org/10.1016/S0016-5085(22)61402-1 |
| work_keys_str_mv | AT ungaroryanc su1480treatmentemergentcovid19infectionsinozanimodulcerativecolitisandmultiplesclerosisclinicaltrials AT siegelcoreya su1480treatmentemergentcovid19infectionsinozanimodulcerativecolitisandmultiplesclerosisclinicaltrials AT creebruce su1480treatmentemergentcovid19infectionsinozanimodulcerativecolitisandmultiplesclerosisclinicaltrials AT selmajkrzysztof su1480treatmentemergentcovid19infectionsinozanimodulcerativecolitisandmultiplesclerosisclinicaltrials AT ahmadharris su1480treatmentemergentcovid19infectionsinozanimodulcerativecolitisandmultiplesclerosisclinicaltrials AT paiashwini su1480treatmentemergentcovid19infectionsinozanimodulcerativecolitisandmultiplesclerosisclinicaltrials AT athershabana su1480treatmentemergentcovid19infectionsinozanimodulcerativecolitisandmultiplesclerosisclinicaltrials AT henryalyssa su1480treatmentemergentcovid19infectionsinozanimodulcerativecolitisandmultiplesclerosisclinicaltrials AT charleslorna su1480treatmentemergentcovid19infectionsinozanimodulcerativecolitisandmultiplesclerosisclinicaltrials AT petersenannkatrin su1480treatmentemergentcovid19infectionsinozanimodulcerativecolitisandmultiplesclerosisclinicaltrials AT chengchunyen su1480treatmentemergentcovid19infectionsinozanimodulcerativecolitisandmultiplesclerosisclinicaltrials AT afsarisonia su1480treatmentemergentcovid19infectionsinozanimodulcerativecolitisandmultiplesclerosisclinicaltrials AT sheffieldjamesk su1480treatmentemergentcovid19infectionsinozanimodulcerativecolitisandmultiplesclerosisclinicaltrials AT vailejohn su1480treatmentemergentcovid19infectionsinozanimodulcerativecolitisandmultiplesclerosisclinicaltrials AT colombeljeanfrederic su1480treatmentemergentcovid19infectionsinozanimodulcerativecolitisandmultiplesclerosisclinicaltrials |